THERAMED HEALTH CORPORATION
USA: EVAHF | Canada: TMED
Last Price: .084 | Website | SEC Filings | Latest News
There’s no doubt that the country is coming around to Legal/Medical Marijuana with all the health and pain medication benefits it provides.
And while Cannabis itself is not yet fully legal in every US State…CBD (Cannabidiol) is!
|WHAT IS CBD?|
Cannabidiol is a phytocannabinoid discovered in 1940. It is one of some 113 identified cannabinoids in cannabis plants and accounts for up to 40% of the plant’s extract. In 2018, clinical research on cannabidiol included preliminary studies of anxiety, cognition, movement disorders, and pain.
Due in part to last year’s landmark Farm Bill which removed hemp as a Schedule I substance and reclassified it as an “agricultural commodity”, CBD that is derived solely from hemp is now Legal Nationwide!
All of this has spurred on a veritable arms race to dominate this potentially very lucrative market which is projected to exceed $3 BIL by 2021!
So needless to say, grabbing a unique foothold in this market NOW has never been more essential. And that’s exactly what Today’s New Alert is doing…
Recently changing their name from Evitrade Health Systems Corp/Auxellence Health Corp, Theramed Health Corp. (EVAHF) is a unique company that melds Science, Health, BioTech, and CBD/Cannabis into one potentially GROUNDBREAKING situation!
EVAHF specializes in the Health and Life Sciences sector looking to deliver effective personalized CBD health solutions and products with a higher degree of predictability and consistency.
All of this is leading to the goal of becoming the FIRST TO OFFER a complete quality-assured vertically integrated ‘CBD Health System’ for monitoring and recording the effects of CBD on your cardiovascular system.
Well that’s exactly why EVAHF is ahead of the game and could be FIRST to market!
YET….EVAHF has flown completely UNDER-THE-RADAR thus far as it trades at a mere 8 CENTS!
That’s why all of this and more could lead to a potentially EXPLOSIVE Situation in both the Short AND Long-Term! So let’s dig in…..
EVAHF NEARING A TRIANGLE PATTERN BREAKOUT?
Dual-Listed stocks sometimes don’t get the attention they deserve.
And while EVAHF is renowned on the Canadian Markets (CSE: TMED), it has been scantly noticed here in the US — even as it trades with the ‘upper crest’ of Small-Cap Stocks on the OTCQB Exchange.
Per our chart, the last few months have shown EVAHF slowly develop a descending Triangle Pattern.
As it approaches it’s zenith, could a Bullish Breakout be near?
We’ll be watching for a break of the upper trend line of our Triangle Pattern as well as the critical 50 Day Moving Average (read line) @ .11 to confirm a New Bullish Trend.
From there, we’ll be watching for a breach of the 200 Day Moving Average (yellow line) at around .18 to take it to the next level.
It’s important to note that EVAHF’s current 52 Week High is .4736 which is 463% HIGHER than the current price.
So what could potentially spur another rally? Read on…
EVAHF IS PERSONALIZING CBD USAGE!
Theramed Health Corporation (EVAHF) – is a technology company specializing in the Health and Life Sciences sector looking to deliver effective personalized health solutions and products with a higher degree of predictability and consistency.
The company is looking to be the first to offer a complete quality assured vertically integrated ‘CBD Health System’ for monitoring and recording the effects of CBD on your cardiovascular system.
EVAHF is focused on the following areas to help improve health:
|► Personalized Medical Care: The Company’s Autonomous Medical Care is engaged in the provision of biomedical online services for common health problems. This online system is aimed primarily at “practicing patients” interested in normalizing blood pressure, blood glucose, and body weight.|
This includes health monitoring via the TULIP™ system that can be utilized for CBD usage monitoring for its effects on your cardiovascular and endocannabinoid system.
TULIP™ is a medical device previously cleared for sales in Canada and Europe as a blood pressure monitor with interactive protocols.
► Molecular Biology: The Company is investigating the impact of increasing the bio-availability of nutraceutical based protocols through the enhancement of molecular structures or delivery systems.
One such is a novel slow release pharmaceutical carrier system to increase water solubility and absorption of CBD or other Active Pharmaceutical Ingredients.
► Pharmaceutical & Nutraceutical Solutions: The Company is investigating the health effects of various natural remedies on the health of consumers either alone or in conjunction with other elements. In focus are various plant based products that are targeted to relieve symptoms such as: Anxiety, Sleeplessness, Chronic inflammation, Fatigue, and High Cholesterol. Initial projects will include Astaxanthin, Spirulina and eventually Cannabinoids.
This includes CBD extractions for improved purity and extractions of nutraceutical solutions and other Active Pharmaceutical Ingredients.
► Genetic Selection: The Company is researching work projects that are focused on creating a homogeneous library of plants through the study and augmentation of the plants core genetics.
EVAHF HEMP EXTRACTION
EVAHF, through it’s subsidiary, Western Agri Solutions Supply Corp, also has a joint venture with a LICENSED Nevada hemp operator to develop a Hemp Extraction Facility.
Through this joint venture, the companies can buy raw hemp and process it through state regulated extraction methodologies.
Already, the companies have performed their first run of its new hemp processing system that provided a crude to distillate run that exceeded expectations. The tests indicated high levels of CBD content which could provide a competitive edge in the marketplace against other competing brands.
Based on these results, EVAHF expects to be starting with a base level of production by the end of this month!
When completed, the facility will be able to process enough hemp to produce approximately 200KG’s of CBD isolate per month!
With this volume of throughput, EVAHF believes they will be able to satisfy their sales channels with it’s own line of premium CBD based products subject to applicable federal and local laws.
THE BOTTOM LINE
EVAHF may have some lofty goals but the company truly appears poised to reach them, and in some instances EXCEED them!
With the company’s recent Joint Venture noted above, they are now positioned to access enough hemp to process highly valuable CBD isolate – as part of their plan to bring premium CBD-based products to market and custom-tailor personalized CBD Health Solutions through a “CBD Health System”.
Needless to say, this is a unique niche’ in the CBD Market that we haven’t seen before — and one that could eventually be utilized in other extracts like THC and more upon nationwide Cannabis legalization!
So it’s clear EVAHF is setting up for a BIG FUTURE.
And at just around 8 CENTS with a potential BREAKOUT Chart Pattern, there may be no better time to check out this high-growth play in both the short and long-term!
Make sure you put EVAHF on your screen RIGHT NOW and Follow on Twitter for Updates + Play-by-Play!